Gadolinium-based distinction agents (GBCAs) are greatly used in magnetic resonance imaging (MRI) to reinforce the visibility of blood vessels, tumors, inflammation, together with other internal constructions. While generally deemed Secure, concerns about GBCA toxicity have emerged in the last two decades—specially in individuals with impaired kid